Rating History for Clovis Oncology (CLVS) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/27/2020 | Andrew Berens | Downgrade | Underperform (Market Perform) |
5.00 (N/A) |
9.03 (0.08) |
-99.11% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
